NorthWest Biotherapeutics Inc (NWBO)

[kabunushi]

Ex, you are dead wrong and/or grossly misleading. You did get me to dig up the Advent financial docs, which you apparently misread completely. You wrote:

BTW, at the end of 2023 Advent did have $25M short term debt that NWBO will acquire, but IMO, that is modest in comparison to what NWBO gets out of the deal.

Advent most definitely did NOT have $25M in debt! That's what NW already owed to Advent as the AP referred to in the PR. NW will not acquire any additional 3rd party debt from Advent.

You must have read the UK balance sheet incorrectly. It lists 'DEBTORS' but those are listed under ASSETS not LIABILITIES! That is almost all AP that NW owed to Advent.

Yes, NW will still have to pay whatever the current AP number is. Pay to whom? Obviously, it will be a payout to Toucan, as Advent will become a NW subsidiary, so what ever that number is, it is the cash payout to Toucan in addition to the 1.4M GBP. BUT again, it's not a debt to any 3rd party that will get added to NW's balance sheet. Because it's already on NW's balance sheet as AP liability.

Including that AP owed by NW (and others?) to Advent, Advent had net assets of 23M GBP.

Handy link to Advent's 2023 financials including balance sheet thru is here, this page:
insert-text-here